Indication
Gastrointestinal Stromal Tumors
4 clinical trials
6 products
Clinical trial
A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Status: Terminated, Estimated PCD: 2024-02-02
Product
THE-630Clinical trial
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal TumorsStatus: Recruiting, Estimated PCD: 2025-07-01
Product
CGT9486Product
SunitinibProduct
TemsirolimusClinical trial
STAR-TOR- REGISTRY FOR THE EVALUATION OF THE SAFETY, TOLERABILITY AND EFFICACY OF TEMSIROLIMUS (TORISEL), SUNITINIB (SUTENT) AND AXITINIB (INLYTA) FOR THE TREATMENT OF SUBJECTS WITH ADVANCED RENAL CELL CARCINOMA (MRCC), MANTLE CELL LYMPHOMA (MCL) AND GASTRO-INTESTINAL STROMA TUMOR (GIST).Status: Completed, Estimated PCD: 2021-12-28
Product
AxitinibClinical trial
A Randomized Multicenter Phase III Trial Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)Status: Completed, Estimated PCD: 2023-12-01
Product
Imatinib